Transcat (NASDAQ:TRNS) Director Sells $47,491.92 in Stock

Transcat, Inc. (NASDAQ:TRNS) Director Christopher Gillette sold 504 shares of the firm’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $94.23, for a total value of $47,491.92. Following the transaction, the director owned 200 shares in the company, valued at approximately $18,846. This trade represents a 71.59% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Transcat Stock Performance

TRNS opened at $93.70 on Friday. The firm has a market cap of $877.03 million, a P/E ratio of 253.24 and a beta of 0.68. Transcat, Inc. has a 52-week low of $50.23 and a 52-week high of $100.00. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.11 and a current ratio of 2.49. The business’s fifty day moving average is $90.05 and its 200-day moving average is $80.70.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings results on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Transcat had a return on equity of 5.56% and a net margin of 0.99%.The company had revenue of $92.95 million for the quarter, compared to analysts’ expectations of $86.55 million. Sell-side analysts expect that Transcat, Inc. will post 1.74 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Weiss Ratings upgraded shares of Transcat from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, May 28th. Wall Street Zen raised shares of Transcat from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Zacks Research raised shares of Transcat from a “strong sell” rating to a “hold” rating in a research note on Friday, May 15th. Finally, Northland Securities downgraded shares of Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 price objective for the company. in a research report on Wednesday, August 5th. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Transcat presently has an average rating of “Hold” and an average target price of $105.50.

Institutional Trading of Transcat

Hedge funds have recently added to or reduced their stakes in the stock. Teachers Retirement System of The State of Kentucky bought a new stake in shares of Transcat during the fourth quarter worth $1,974,000. Needham Investment Management LLC lifted its stake in shares of Transcat by 33.0% in the 4th quarter. Needham Investment Management LLC now owns 124,370 shares of the scientific and technical instruments company’s stock valued at $7,056,000 after acquiring an additional 30,870 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Transcat by 3.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 262,033 shares of the scientific and technical instruments company’s stock valued at $19,244,000 after acquiring an additional 9,266 shares during the last quarter. Fifth Third Bancorp boosted its holdings in shares of Transcat by 6,267.8% during the 1st quarter. Fifth Third Bancorp now owns 47,886 shares of the scientific and technical instruments company’s stock valued at $3,517,000 after acquiring an additional 47,134 shares in the last quarter. Finally, Royce & Associates LP boosted its holdings in shares of Transcat by 15.3% during the 4th quarter. Royce & Associates LP now owns 390,546 shares of the scientific and technical instruments company’s stock valued at $22,156,000 after acquiring an additional 51,774 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.